Echo assessment in AF
- LA volume index - chronically elevated in AF; LAVI > 34 mL/m² common; > 48 mL/m² severely enlarged.
- LAA emptying velocity on TEE - < 20 cm/s → high thrombus risk.
- SEC (spontaneous echo contrast) - swirling smoke-like echoes; marker of stasis and embolic risk.
- Loss of atrial contraction - no A wave on mitral inflow.
Cardioversion decision
- AF duration > 48 hr (or unknown) → need therapeutic anticoagulation for 3 weeks OR pre-cardioversion TEE to rule out LAA thrombus.
- After cardioversion, continue anticoagulation for at least 4 weeks (atrial stunning window even after rhythm restored).
Diastolic assessment in AF
- Cannot use E/A ratio (no A wave).
- Alternative markers of elevated LAP:
- Deceleration time (DT) < 160 ms with reduced EF.
- E acceleration rate > 1900 cm/s².
- IVRT ≤ 65 ms.
- E/e′ ≥ 11.
- TR peak velocity.
- Average across 5+ beats for accuracy.
LAA closure devices
- Watchman, Amulet - implanted via TEE guidance.
- Post-procedure follow-up TEE at 45 days and 1 year to confirm complete seal.
- Peri-device leak > 5 mm considered significant.
MAZE / PVI-associated echo findings
- Post-ablation LA stunning: attenuated A wave despite return of electrical p-wave.
- Rare complication: PV stenosis, atrio-esophageal fistula.
AF-related cardiomyopathy
- Tachycardia-mediated CM: reversible LV dysfunction from persistent rapid rates.
- Rate control (< 110) or rhythm control can reverse it.